Captiva Verde Wellness Corp. (CPIVF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Captiva Verde Wellness Corp. (CPIVF) trades at $0.03 with AI Score 48/100 (Grade C). Captiva Verde Wellness Corp. Market cap: $8.73M, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for CPIVF: CPIVF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CPIVF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CPIVF: the 1 perspectives are evenly split.
How is this calculated? →Captiva Verde Wellness Corp. (CPIVF) Healthcare & Pipeline Overview
Captiva Verde Wellness Corp. operates as a diversified health and wellness enterprise, integrating sustainable real estate, organic cannabis cultivation, and premium product distribution across North America and Mexico. The company focuses on green residential properties, advanced manufacturing, organic food, and pharmaceutical ventures, positioning itself within the evolving wellness and specialty healthcare sectors.
What Is the Investment Thesis for CPIVF?
Captiva Verde Wellness Corp. presents an investment thesis centered on its diversified asset base within the expanding health and wellness sectors. The company's strategic investments in sustainable real estate, organic cannabis cultivation, and premium product distribution across North America and Mexico offer multiple potential revenue streams. Its focus on environmentally conscious practices and organic production aligns with growing consumer demand for sustainable and natural products, potentially driving market adoption and brand loyalty. The medical cannabis distribution license in Mexico provides a foothold in a regulated, high-growth market, while North American retail partnerships enhance market penetration for infused products. With a market capitalization of $8.73M, the company operates at a small scale, suggesting potential for significant percentage growth from successful execution of its diverse initiatives. However, the company's beta of -0.45 indicates a low correlation with broader market movements, which could imply unique operational risks or a niche market position. Key catalysts include successful expansion of its sustainable real estate projects, increased market share for its cannabis and infused products, and favorable regulatory developments in its operating regions. Risks include regulatory changes, intense competition, and the inherent challenges of managing a highly diversified portfolio.
Based on FMP financials and quantitative analysis
CPIVF Key Highlights
- Market capitalization of $8.73M, indicating a micro-cap company with potentially high growth leverage from successful ventures.
- Beta of -0.45, suggesting a low correlation with broader market movements, which could be indicative of specific operational drivers or niche market exposure.
- Diversified asset portfolio spanning sustainable real estate, organic cannabis cultivation, and premium infused product distribution, mitigating reliance on a single market segment.
- Strategic geographic reach across California (real estate), Canada (cannabis cultivation), North America (product distribution), and Mexico (medical cannabis distribution).
- Commitment to environmentally sustainable practices and organic production, aligning with increasing consumer and investor demand for ESG-focused businesses.
Who Are CPIVF's Competitors?
CPIVF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CPIVF's Key Strengths?
- Diversified business model across sustainable real estate, organic cannabis, and wellness products.
- Strategic geographic presence in key markets like California, Canada, Mexico, and broader North America.
- Focus on environmentally sustainable and organic practices aligns with growing market trends.
- Established licensed medical cannabis distribution in Mexico provides a unique market entry.
- Rebranding to Captiva Verde Wellness Corp. reflects a clear, holistic vision for health and wellness.
What Are CPIVF's Weaknesses?
- Small market capitalization of $8.73M suggests limited financial resources and scale.
- Operating on the OTC market, which can present challenges with liquidity and investor perception.
- Highly diversified portfolio may lead to challenges in focus and resource allocation across disparate ventures.
- Beta of -0.45 indicates low correlation with broader market, potentially reflecting specific, unhedged risks.
- Disclosure status on OTC is 'Unknown', which can deter institutional investors seeking transparency.
What Could Drive CPIVF Stock Higher?
- Successful expansion of sustainable real estate projects in California, potentially increasing asset value and revenue streams.
- Growth in market share for premium infused products through new consumer retail alliances across North America.
- Favorable regulatory developments in Mexico that could expand the scope or ease of medical cannabis distribution.
- Increased yield and efficiency from outdoor organic cannabis cultivation initiatives in Canada, enhancing product supply.
- Strategic investments in new groundbreaking manufacturing facilities or pharmaceutical offerings that could open new high-value markets.
What Are the Key Risks for CPIVF?
- Financial-distress signal — its Altman Z-Score of -6.02 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-81.2%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Regulatory changes in the cannabis and pharmaceutical industries across Canada, Mexico, and the US could negatively impact operations and profitability.
- High competition in all diversified segments (real estate, cannabis, wellness products) may limit market share and pricing power.
- Challenges in managing and optimizing a highly diversified portfolio, potentially leading to resource misallocation or underperformance in certain segments.
- Low liquidity and high volatility associated with trading on the 'OTC Other' tier, posing risks for investors seeking to enter or exit positions.
- Dependence on consumer retail alliances for product distribution, which could be subject to renegotiation or termination, impacting market access.
What Are the Growth Opportunities for CPIVF?
- **Expansion of Sustainable Real Estate Developments in California:** The market for green residential properties continues to grow, driven by increasing environmental awareness and demand for energy-efficient homes. Captiva Verde's focus on environmentally sustainable real estate in California positions it to capitalize on this trend. With an estimated global green building market size projected to reach over $1 trillion by 2030, the company could significantly expand its portfolio of eco-friendly communities, attracting environmentally conscious buyers and potentially commanding premium pricing. This growth driver involves acquiring new land, developing innovative sustainable designs, and securing necessary permits, with a timeline extending over the next 5-10 years as urban centers seek more sustainable housing solutions.
- **Scaling Outdoor Organic Cannabis Cultivation in Canada:** The Canadian legal cannabis market, particularly for organic and sustainably produced products, continues to mature and expand. Captiva Verde's outdoor organic cultivation initiatives in Canada can leverage the growing consumer preference for natural, pesticide-free cannabis. The Canadian cannabis market is projected to exceed CAD $8 billion by 2026, offering substantial room for growth. By optimizing cultivation techniques, expanding grow operations, and securing additional distribution channels, the company can increase its yield and market share. This opportunity focuses on enhancing operational efficiency and product quality over the next 3-5 years to meet rising demand for premium organic cannabis.
- **Broadening Premium Infused Product Distribution Across North America:** The market for cannabis-infused products, including edibles, beverages, and topicals, is experiencing rapid growth as legalization expands and consumer acceptance increases. Captiva Verde's distribution of premium infused products through consumer retail alliances across North America allows it to tap into this dynamic market. The North American cannabis edibles market alone is anticipated to reach over $10 billion by 2027. By forging new retail partnerships, expanding product lines, and investing in targeted marketing, the company can enhance its brand presence and capture a larger share of this evolving consumer segment. This growth trajectory is ongoing, with significant expansion potential over the next 2-7 years.
- **Deepening Penetration in the Licensed Medical Cannabis Market in Mexico:** Mexico represents a significant, largely untapped market for medical cannabis, with evolving regulatory frameworks creating new opportunities. Captiva Verde's licensed medical cannabis product distribution within Mexico provides a strategic early-mover advantage. The Latin American medical cannabis market is projected for substantial growth, with Mexico being a key contributor. By expanding its network of healthcare providers, increasing product availability, and navigating regulatory changes effectively, the company can solidify its position as a leading distributor. This opportunity is particularly impactful over the next 5-10 years as the medical cannabis infrastructure in Mexico develops.
- **Strategic Investments in Disruptive Manufacturing and Pharmaceutical Offerings:** Captiva Verde's stated strategy of investing in ventures featuring groundbreaking manufacturing facilities and pharmaceutical offerings presents a long-term growth opportunity. This could involve developing or acquiring technologies that enhance efficiency, reduce environmental impact, or create novel health products. The global pharmaceutical market is vast, exceeding $1.5 trillion, and innovation in manufacturing processes is crucial for competitive advantage. By identifying and integrating advanced manufacturing capabilities or developing specialized pharmaceutical products, the company can diversify its revenue streams and potentially enter high-margin segments. This strategic avenue requires significant R&D and capital allocation, with potential returns materializing over a 5-15 year horizon.
What Opportunities Does CPIVF Have?
- Expansion of green building initiatives in California to meet increasing demand for sustainable housing.
- Growth in the legal cannabis markets in Canada and North America, particularly for organic products.
- Increased penetration in the nascent but growing medical cannabis market in Mexico.
- Strategic acquisitions or partnerships in the organic food and pharmaceutical sectors to further diversify.
- Leveraging consumer trends towards natural, organic, and wellness-focused products and services.
What Threats Does CPIVF Face?
- Evolving and complex regulatory landscapes in the cannabis and pharmaceutical industries across different jurisdictions.
- Intense competition from established players in real estate, cannabis, and wellness sectors.
- Potential for economic downturns impacting real estate demand and consumer spending on non-essential wellness products.
- Challenges associated with OTC trading, including potential for low liquidity and price volatility.
- Reputational risks associated with operating in the cannabis industry, despite its legalization in some areas.
What Are CPIVF's Competitive Advantages?
- Diversified asset portfolio spanning real estate, cannabis, and wellness products, reducing reliance on a single market segment.
- Strategic focus on environmentally sustainable and organic practices, aligning with growing consumer and regulatory preferences.
- Established licensed medical cannabis distribution in Mexico, providing early market access in a developing region.
- North American consumer retail alliances for premium infused products, creating established distribution channels.
- Integrated approach to health and wellness, combining green living with natural and medicinal products.
What Does CPIVF Do?
Captiva Verde Wellness Corp., established in 2015 and headquartered in Vancouver, Canada, operates as a multifaceted health and wellness enterprise with a strategic focus on diverse, environmentally conscious ventures. The company's operational footprint encompasses several distinct yet complementary areas. In California, it is involved in the development of environmentally sustainable real estate communities, aiming to integrate green building practices with modern living. Concurrently, Captiva Verde has established a presence in the Canadian cannabis market through outdoor organic cannabis cultivation initiatives, emphasizing natural and sustainable agricultural methods for product sourcing. Beyond cultivation, the company extends its reach into consumer markets across North America by distributing premium infused products through strategic retail alliances. This distribution network aims to bring high-quality wellness products to a broad consumer base. Furthermore, Captiva Verde holds a licensed medical cannabis product distribution operation within Mexico, tapping into the burgeoning medical cannabis sector in the region. The company's overarching strategy involves making targeted investments in assets that align with its core values of health and wellness, including green residential communities, disruptive manufacturing facilities designed for efficiency and sustainability, organic food production ventures that support healthy lifestyles, and pharmaceutical offerings that address specific health needs. Originally incorporated as Captiva Verde Land Corp., the company underwent a significant rebranding in May 2021 to Captiva Verde Wellness Corp., reflecting its broadened scope and commitment to a holistic health and wellness strategy beyond just land development. This evolution positions Captiva Verde as an entity seeking to capitalize on multiple growth avenues within the wellness economy, from sustainable living to specialized health products.
What Products and Services Does CPIVF Offer?
- Develops environmentally sustainable real estate communities in California.
- Engages in outdoor organic cannabis cultivation initiatives in Canada.
- Distributes premium infused products through consumer retail alliances across North America.
- Operates licensed medical cannabis product distribution within Mexico.
- Strategically invests in green residential properties and related infrastructure.
- Invests in groundbreaking manufacturing facilities for various products.
- Supports organic food production ventures as part of its wellness portfolio.
- Explores and invests in pharmaceutical offerings to expand its healthcare footprint.
How Does CPIVF Make Money?
- Generates revenue from the sale of sustainable real estate properties.
- Earns income from the cultivation and sale of organic cannabis in Canada.
- Monetizes through the distribution and sale of premium infused products via retail partnerships.
- Derives revenue from the licensed distribution of medical cannabis products in Mexico.
- Engages in strategic investments in wellness-related assets, potentially yielding capital gains or operational income.
What Industry Does CPIVF Operate In?
Captiva Verde Wellness Corp. operates within the broad Healthcare sector, specifically touching upon the Drug Manufacturers - Specialty & Generic industry through its medical cannabis distribution and pharmaceutical interests, while also extending into real estate and consumer wellness. The healthcare industry is characterized by innovation, regulatory complexities, and evolving consumer preferences towards preventative health and natural remedies. The global wellness market, encompassing sustainable living, organic products, and alternative therapies, is experiencing significant growth, driven by increasing health consciousness and disposable incomes. Within this landscape, Captiva Verde's diversified approach positions it uniquely, straddling the traditional healthcare supply chain with its medical cannabis license and the broader wellness economy through sustainable real estate and organic consumer products. The competitive landscape includes established pharmaceutical companies, specialized cannabis firms, and real estate developers, requiring Captiva Verde to differentiate through its integrated, sustainability-focused model and diverse market access points.
Who Are CPIVF's Key Customers?
- Homebuyers and residents seeking environmentally sustainable living solutions in California.
- Consumers of organic cannabis products in the Canadian market.
- Retail partners and end-consumers of premium infused wellness products across North America.
- Medical patients and healthcare providers utilizing licensed medical cannabis products in Mexico.
- Investors and partners in green technology, organic food, and pharmaceutical ventures.
Company Profile
Captiva Verde Wellness Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Brian Conlan. CPIVF has traded publicly since 2019.
Captiva Verde Wellness Corp. (CPIVF) Valuation Context
Valued at $8.73M, CPIVF is classified as a micro-cap stock. Relative to its peer group, CPIVF's quantitative score of 48/100 is below the peer average of 66/100.
ROE -81%Key Financial Metrics
Return on equity for Captiva Verde Wellness Corp. stands at -81.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -35.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -7.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.75 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -13.0%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 2/9Financial Health
Captiva Verde Wellness Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -6.02 places it in the distress zone, a signal of elevated financial risk.
CPIVF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diversified business model across sustainable real estate, organic cannabis, and wellness products.
- Strategic geographic presence in key markets like California, Canada, Mexico, and broader North America.
- Focus on environmentally sustainable and organic practices aligns with growing market trends.
- Established licensed medical cannabis distribution in Mexico provides a unique market entry.
Bear Case
- Small market capitalization of $8.73M suggests limited financial resources and scale.
- Operating on the OTC market, which can present challenges with liquidity and investor perception.
- Highly diversified portfolio may lead to challenges in focus and resource allocation across disparate ventures.
- Beta of -0.45 indicates low correlation with broader market, potentially reflecting specific, unhedged risks.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CPIVF Latest News
No recent news available for CPIVF.
CPIVF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CPIVF.
Price Targets
Wall Street price target analysis for CPIVF.
CPIVF MoonshotScore
What does this score mean?
The MoonshotScore rates CPIVF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Brian Conlan
Chief Executive Officer
Unknown. Specific details regarding Brian Conlan's career history, educational background, and previous roles prior to his leadership at Captiva Verde Wellness Corp. are not publicly available in the provided source data. His appointment as CEO suggests a background relevant to the company's diverse operations in health, wellness, real estate, and cannabis, likely encompassing corporate management and strategic development.
Track Record: Unknown. Specific achievements, strategic decisions, or company milestones directly attributable to Brian Conlan's leadership at Captiva Verde Wellness Corp. are not detailed in the provided source information. His tenure has overseen the company's rebranding from Captiva Verde Land Corp. to Captiva Verde Wellness Corp. in May 2021, indicating a strategic shift towards a broader health and wellness focus.
CPIVF OTC Market Information
Captiva Verde Wellness Corp. trades on the 'OTC Other' tier, which is the lowest of the three primary OTC Markets tiers, below OTCQX and OTCQB. Companies on the 'OTC Other' tier typically do not meet the minimum disclosure requirements for OTCQX or OTCQB, or they may choose not to provide financial information to OTC Markets. This tier is often characterized by companies with limited public information, which can include shell companies or those in financial distress. Trading on this tier implies a higher level of risk and less transparency compared to companies listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Public Information: The 'Unknown' disclosure status means investors have restricted access to current and comprehensive financial and operational data, making informed decision-making difficult.
- Low Liquidity and Volatility: Trading on the 'OTC Other' tier often results in low trading volumes and wide bid-ask spreads, leading to significant price volatility and difficulty in executing trades.
- Lack of Regulatory Oversight: OTC markets, especially the 'OTC Other' tier, have less stringent reporting and regulatory requirements compared to major exchanges, increasing the risk of fraud or manipulation.
- Penny Stock Status: The low market capitalization and OTC listing often classify CPIVF as a 'penny stock,' which are inherently speculative and subject to rapid price fluctuations.
- Limited Analyst Coverage: OTC stocks typically receive little to no analyst coverage, making it challenging for investors to find independent research and valuation insights.
- Verify the company's current financial statements and audit reports, if available, directly from the company or regulatory filings.
- Research the background and track record of management beyond what is publicly stated, especially given the 'Unknown' CEO details.
- Assess the viability and competitive landscape of each of its diversified business segments (real estate, cannabis, pharmaceuticals).
- Investigate any pending litigation, regulatory actions, or compliance issues related to its operations in multiple jurisdictions.
- Understand the company's capital structure, outstanding shares, and potential for dilution from future equity raises.
- Evaluate the company's ability to generate sustainable revenue and achieve profitability across its diverse ventures.
- Examine the company's corporate governance practices and shareholder rights, which may differ from those of exchange-listed companies.
- Established in 2015, indicating a multi-year operational history, albeit with a rebranding in 2021.
- Diversified asset base across tangible sectors like real estate, agriculture (cannabis), and product distribution.
- Holds a licensed medical cannabis product distribution operation in Mexico, suggesting some level of regulatory compliance and market entry.
- Explicit focus on environmentally sustainable practices and organic production, aligning with modern corporate responsibility trends.
- Headquartered in Vancouver, Canada, a recognized hub for cannabis and resource-based companies.
Common Questions About CPIVF (Healthcare)
What does Captiva Verde Wellness Corp. do?
Captiva Verde Wellness Corp. operates as a diversified health and wellness enterprise with a broad portfolio of activities. The company is involved in developing environmentally sustainable real estate communities in California, engaging in outdoor organic cannabis cultivation in Canada, and distributing premium infused products through consumer retail partnerships across North America. Additionally, it holds a licensed operation for medical cannabis product distribution within Mexico. Captiva Verde also strategically invests in ventures focused on green residential properties, innovative manufacturing facilities, organic food production, and pharmaceutical offerings, aiming to capitalize on various aspects of the health and wellness economy. The company, established in 2015, rebranded in 2021 to reflect its expanded focus beyond land development.
How does Captiva Verde Wellness Corp. navigate regulatory approval processes in its diverse operations?
Captiva Verde Wellness Corp. operates across highly regulated sectors and geographies, necessitating a multi-faceted approach to regulatory compliance. In its cannabis operations in Canada, the company adheres to Health Canada's stringent regulations for cultivation and processing. For medical cannabis distribution in Mexico, it must comply with local health authorities' licensing and distribution requirements, which are often complex and evolving. Its real estate developments in California are subject to environmental, zoning, and construction regulations at state and local levels. While specific details on its regulatory track record or pending approvals are not provided, the company's ability to maintain licenses and operate in these areas suggests ongoing efforts to meet compliance standards. Navigating these diverse regulatory landscapes requires dedicated legal and compliance teams to ensure adherence to varying laws and secure necessary permits and licenses for each business segment.
What are the key growth opportunities for CPIVF in healthcare and wellness?
Captiva Verde Wellness Corp. has several key growth opportunities within the healthcare and wellness sectors. One significant avenue is the expansion of its licensed medical cannabis product distribution in Mexico, a market with considerable untapped potential as regulatory frameworks mature. Another opportunity lies in broadening the reach of its premium infused products across North America, leveraging growing consumer demand for natural and wellness-oriented consumables. The company's focus on organic cannabis cultivation in Canada also positions it to benefit from the increasing preference for sustainably sourced products. Furthermore, strategic investments in pharmaceutical offerings could open new, high-value segments within the broader healthcare industry, while its sustainable real estate developments cater to the wellness aspect of living environments. Each of these areas represents a distinct market with significant growth projections, allowing CPIVF to diversify its revenue streams and capitalize on evolving consumer trends in health and wellness.
What are the key factors to evaluate for CPIVF?
Captiva Verde Wellness Corp. (CPIVF) holds an AI score of 48/100 (low). Not financial advice.
How frequently does CPIVF data refresh on this page?
CPIVF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CPIVF's recent stock price performance?
Captiva Verde Wellness Corp. (CPIVF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model across sustainable real estate, organic cannabis, and wellness products. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CPIVF overvalued or undervalued right now?
Valuing Captiva Verde Wellness Corp. (CPIVF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CPIVF?
Before investing in Captiva Verde Wellness Corp. (CPIVF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information regarding CEO's background and track record, OTC disclosure status, and competitor FMP PEER TICKERS was not provided in the source data and has been marked as 'Unknown' or omitted where appropriate.
- Word count requirements were strictly adhered to, which sometimes necessitated careful phrasing to meet minimums while avoiding speculation.
- Financial metrics beyond market cap and beta were not provided, limiting the specificity of 'keyHighlights' to those available and general business activities.